LifeStance Health's Q2: adjusted EBITDA nearly doubled to $66M (+94% YoY), 2026 revenue guidance raised to $1.685-1.725B, and tuck-in M&A resumed after a pause (critic catch — BHB's 08-06 lead; this scaled, publicly traded outpatient mental-health provider network had no watchlist term at all until this pass added one). (BHB)
2026-08-06
